Immuno-oncology therapy developer Lava Therapeutics has filed for a $100m IPO, having been set up in 2016 to exploit Amsterdam University Medical Centers research.

Ping An and Alphabet-backed health insurer Oscar priced an upsized offering on the New York Stock Exchange above its range to raise $1.44bn.

Microsoft, Porsche and Siemens have all scored another win as Markforged pursues a reverse merger that will net it $425m in gross proceeds.

SoftBank’s robotics portfolio company Berkshire Grey has lined up a reverse merger with Revolution Acceleration Acquisition Corp and will be valued at $2.7bn.

Having abandoned plans for an IPO three years ago, ReNew Power has now settled on a reverse merger and will secure proceeds worth $1.2bn.

The Intel Capital, JetBlue Technology Ventures, Toyota AI Ventures and Uber-backed flying car developer is set to list on the NYSE.

The business software producer is set to float in a $172m offering on TSE that will enable Data Applications, Itochu, Pksha, Sansan, Suzuyo, SystemExe, Teikoku DataBank and Toshiba Digital Solutions to exit.

Fresenius Medical Care and Access Industries-backed Humacyte will merge with Alpha Healthcare Acquisition Corp to become a public business with a market cap of $1.1bn.

Aisin, Airbus, Intel, LG, SBI, Hella and SK Hynix all celebrated a win as AEye agreed to a reverse merger with CF Finance to list on Nasdaq at a $2bn valuation.

Cloopen, also known as Ronglian and Yuntongxun, priced its shares at $16 to raise $320m in an initial public offering that provided an exit for Telstra Ventures and New Oriental.